Prevention & Risk Reduction

Chronic coronary syndromes can more than triple a person's chances of developing diabetes, researchers found. 

Researchers used ultrasound imaging to examine the hearts of young adults who smoked marijuana and those who did not. Their full analysis was published in the Journal of Applied Physiology

The team sees significant potential in its findings, though they still hope to make the technique "simpler and more clinically implementable."

Typically used to treat Type 2 diabetes, metformin may also provide value as a treatment option for a serious, potentially fatal kidney disease. 

Researchers reviewed data from 34 different studies, covering a total of more than 63,000 patients.

Rita Rastogi Kalyani, MD, an endocrinologist and associate professor at Johns Hopkins Medicine, shared her perspective on this crucial topic. 

After 24 weeks, treatment with sotatercept was associated with a significant reduction in pulmonary vascular resistance.

The study, published in Hypertension, included data from more than 8,000 U.S. veterans.

The medication, a PCSK9 inhibitor, was already an approved therapy for adult patients with cardiovascular disease.

The study's authors warned that excess deaths may continue to rise if states don't learn any lessons from the last year. 

The findings, published in JAMA Cardiology, confirm that dapagliflozin is a safe, effective treatment option for patients with heart failure with reduced ejection fraction.

The study's authors tracked the health of more than 134,000 individuals from 21 countries for nearly a decade.